Get started

Longs

Trade Idea: US30 Long ( BUY LIMIT )1. Technical Analysis Breakdown: Daily Chart: • Trend: Bullish overall, but showing signs of pullback. • MACD: Bearish, indicating weakening momentum. • RSI: At 45.23 — neutral but leaning toward oversold territory. • Support level: Around 41,500. • Resistance level: Recent high near 42,890. 15-Min Chart: • Trend: Strong intraday upward momentum. • MACD: Bullish crossover with momentum building. • RSI: 69.09 — nearing overbought but still has room. • Support: Around 41,760. • Resistance: 42,208 (current price), next major level at 42,500. 3-Min Chart: • Trend: Short-term bullish with a slight consolidation. • MACD: Flat, showing a pause but no reversal yet. • RSI: 53.19 — mid-range, suggesting more upside potential. ⸻ 2. Fundamental Analysis: • US economy shows resilience (strong job data, improved GDP). • Fed’s stance on rates remains balanced, leaning dovish, supporting equities. • Geopolitical tensions slightly cooling, risk appetite growing. ⸻ 3. Trade Plan — Long Position (Buy) • Entry: 42,210 (after a clean break above consolidation). • Stop Loss (SL): 41,900 (below recent intraday support). • Take Profit (TP): 42,830 (previous daily high). FUSIONMARKETS:US30
FUSIONMARKETS:US30Long
by KeN-WeNzEl
Trade Idea: US30 Long ( BUY LIMIT ) Technical Analysis: 1. Daily Chart (Long-Term View): • The price has recently pulled back but remains in a long-term uptrend. • The MACD is negative, indicating past selling pressure, but it is starting to turn, which suggests momentum may shift bullish. • The RSI is at 47.54, close to neutral, meaning there is room for upside movement without being overbought. 2. 15-Minute Chart (Intraday Trend): • The price is recovering after a dip. • MACD is deeply negative, suggesting it may be at a bottom, and a reversal could happen. • The RSI at 48.27 is near neutral, indicating a potential bullish move. 3. 3-Minute Chart (Entry Timing): • A small uptrend has started, and the price is crossing above the short-term moving average. • The MACD is turning positive, signaling a potential bullish push. • RSI is above 50 (56.24), confirming strength in the short term. ⸻ Fundamental Analysis: • Market sentiment remains bullish overall for US indices due to strong economic data. • Dow Jones remains in an uptrend on the higher timeframes, and recent dips are likely just corrections before another push higher. • Liquidity conditions and central bank policy support equities. ⸻ Trade Setup: Entry: 42,400 (current price area where price is stabilizing) Stop Loss (SL): 42,250 (below recent support, keeping risk low) Take Profit (TP): 42,800 (previous resistance level) FUSIONMARKETS:US30
FUSIONMARKETS:US30Long
by KeN-WeNzEl
Start adjusting before April tariff policy ! XAU ✍️ NOVA hello everyone, Let's comment on gold price next week from 03/24/2025 - 03/28/2025 🔥 World situation: Gold prices decline for the second consecutive day but remain on track to close the week in positive territory, despite a stronger US Dollar (USD) and profit-taking ahead of the weekend. XAU/USD is currently trading at $3,019, down 0.81%. Market sentiment remains cautious, though US equities are paring earlier losses. Meanwhile, bullion stays on the defensive as the USD regains momentum, with the US Dollar Index (DXY) edging up to 104.05, marking a 0.24% increase. 🔥 Identify: Gold prices are in a short-term downtrend in the H4 frame, adjusting at the end of March, accumulating before tax policies in early April 2025. 🔥 Technically: Based on the resistance and support areas of the gold price according to the H4 frame, NOVA identifies the important key areas as follows: Resistance: $3057, $3080 Support : $2982, $2910 🔥 NOTE: Note: Nova wishes traders to manage their capital well - take the number of lots that match your capital - Takeprofit equal to 4-6% of capital account - Stoplose equal to 2-3% of capital account - The winner is the one who sticks with the market the longest
OANDA:XAUUSDShort
by Nova-Scalper
2
Why Invest in CONMED Corp (CNMD)?Why Invest in CONMED Corp (CNMD)? Strong Earnings Growth – CONMED has experienced a remarkable increase in earnings, with EPS surging by 104% year-over-year and net income rising by 105% YoY. This indicates strong financial performance and profitability momentum. Attractive Valuation – The stock is currently trading at a P/E ratio of 13.79, which is significantly lower than its historical averages. This suggests that CNMD may be undervalued relative to its past performance and industry peers. Consistent Revenue Growth – The company reported revenue of $1.31 billion for the last year, marking a 5% increase compared to the previous period. This steady growth highlights CNMD’s ability to expand its market presence. Improving Margins and Efficiency – CONMED has seen an increase in operating income (+66% YoY), operating margin (+58% YoY), and return on assets (+104% YoY), demonstrating better cost management and operational efficiency. Dividend and Low Payout Ratio – The company pays a dividend of $0.80 per share, yielding approximately 1.35%, with a conservative payout ratio of 18.6%. This allows room for future dividend increases while maintaining financial flexibility. Healthcare Sector Stability – As a medical technology company specializing in surgical devices, CONMED operates in a defensive sector that tends to be resilient during economic downturns. This provides investors with a level of stability. Solid Balance Sheet and Liquidity – The company has a current ratio of 2.3, indicating strong short-term liquidity. Additionally, its quick ratio of 0.94 suggests it can cover its immediate liabilities effectively. Final Thoughts: CONMED presents a compelling investment case due to its strong earnings growth, attractive valuation, improving profitability, and stable position in the healthcare sector. However, potential investors should always consider market conditions and individual risk tolerance before making investment decisions.
NYSE:CNMDLong
by ForexCompany
Reasons to Invest in CVS Health (CVS)Reasons to Invest in CVS Health (CVS) Strong Market Position CVS Health is a leading healthcare company with a diversified business model, including retail pharmacies, insurance, and healthcare services. Its extensive network provides a competitive advantage. Attractive Valuation CVS is currently trading at a P/E ratio of approximately 12.23, which is lower than its historical average of 17.55. This suggests the stock may be undervalued compared to its long-term performance【41】. Consistent Free Cash Flow (FCF) The company generates significant free cash flow, which allows it to invest in growth, reduce debt, and return capital to shareholders. Dividend and Shareholder Returns CVS has a stable dividend policy with a payout ratio that allows for sustainable growth while reinvesting in the business【40】. Resilient Business Model The healthcare industry is defensive, meaning CVS can perform well even in economic downturns. The company benefits from consistent demand for prescriptions and healthcare services. Future Growth Potential CVS is expanding its healthcare services through acquisitions and technology-driven solutions. Investments in Medicare, pharmacy benefits, and digital health are expected to drive long-term growth. Would you like a deeper fundamental comparison between CVS and its competitors?
NYSE:CVSLong
by ForexCompany
Trade Idea: XAUUSD LONG (BUY LIMIT)Technical Analysis: 1. Trend Analysis: • 1H Chart: Clear uptrend with a pullback and price stabilizing near 2918. • 15M Chart: Price has been consolidating after a recovery from a dip. • 3M Chart: Market is forming higher lows, showing strength. 2. Indicators: • MACD: • 1H Chart: Bullish momentum, MACD line above signal line. • 15M Chart: MACD recovering from a dip. • 3M Chart: Weakening bearish momentum, signaling potential reversal. • RSI: • 1H Chart: 53.84 (neutral, with room for upside). • 15M Chart: 50.50 (balanced, indicating neither overbought nor oversold). • 3M Chart: 57.78 (leaning bullish). 3. Support & Resistance Levels: • Support: 2910, 2895 • Resistance: 2928, 2946 Fundamental Analysis: • Gold’s recent movement is supported by: • Dollar weakness due to expectations of Fed rate cuts. • Geopolitical uncertainty keeping gold as a safe-haven asset. • U.S. Treasury Yields stabilizing, giving gold more upside room. Trade Execution: • Entry: 2918 • Stop Loss (SL): 2908 (10 points) • Take Profit (TP): 2938 (20 points) • Risk-Reward Ratio: 2:1 Rationale for Trade: • Momentum is bullish across timeframes. • Good confluence of technical and fundamental factors supporting upside. • Risk is well-managed with a strong RRR of 2:1. FUSIONMARKETS:XAUUSD
FUSIONMARKETS:XAUUSDLong
by KeN-WeNzEl
Trade Idea: XAUUSD Long ( BUY LIMIT )Technical Analysis: 1. Trend Analysis: • H1: Uptrend resuming after a pullback. MACD histogram turning positive, indicating bullish momentum. RSI at 59.21, showing strength but not overbought. • M15: Price recently broke above resistance and is holding above it. MACD near zero but turning positive, supporting bullish continuation. RSI is neutral at 50.36, leaving room for further upside. • M3: Strong breakout and consolidation. MACD is positive, and RSI at 52.73 shows bullish strength. 2. Support & Resistance: • Key support: 2900 • Key resistance: 2945 3. Moving Average Confirmation: • On all timeframes, the price is holding above the moving average, signaling bullish continuation. Fundamental Analysis: • Gold is benefiting from safe-haven demand amid global uncertainties. • US Dollar Index (DXY) has been weakening, which supports gold’s upside. • Upcoming economic data (if dovish) may further push gold higher. Trade Execution: • Entry: 2915 (Current price) • Stop-Loss (SL): 2900 (Below key support) • Take-Profit (TP): 2945 (Key resistance level) FUSIONMARKETS:XAUUSD
FUSIONMARKETS:XAUUSDLong
by KeN-WeNzEl
Trade Idea: XAUUSD LONG (BUY LIMIT) Technical Analysis 1. 1H Chart (Higher Timeframe Trend) • Downtrend Reversal: Price was in a strong downtrend but is now bouncing off a key support near 2827-2830. • MACD: Histogram is reducing bearish momentum, suggesting a possible trend reversal. • RSI (14): Rising from oversold conditions (~54.89), indicating bullish momentum building up. 2. 15-Min Chart (Intraday Confirmation) • Reversal Pattern: A sharp recovery from lows around 2849, forming higher lows. • MACD: Bullish crossover with histogram turning positive, confirming bullish momentum. • RSI (12): Nearing overbought levels (~68.23), but still has room for continuation. 3. 3-Min Chart (Entry Timing) • Pullback to Support: Price is consolidating after a strong breakout above 2862. • MACD: Still showing bullish structure but a minor pullback is visible. • RSI (10): Neutral at 50.89, meaning price is neither overbought nor oversold, ideal for a continuation entry. Fundamental Analysis • Gold Demand: Potentially rising due to economic uncertainty, with investors looking for safe-haven assets. • USD Weakness: If upcoming economic data (e.g., inflation, job reports) indicate a slowing U.S. economy, gold could gain strength. • Market Sentiment: If risk-off sentiment continues, gold could push higher. Trade Execution Position: Long XAU/USD • Entry: 2865 (After minor pullback confirmation) • Stop Loss: 2855 (Below recent pullback low) • Take Profit: 2890 (Near previous resistance level) • Risk-Reward Ratio (RRR): 2.5:1 Rationale • The uptrend reversal is forming on the 1H and 15M charts. • Momentum indicators (MACD & RSI) support a bullish move. • Strong demand and potential USD weakness could fuel further upside. FUSIONMARKETS:XAUUSD
FUSIONMARKETS:XAUUSDLong
by KeN-WeNzEl
1
#GALAUSDT is breaking resistance – expecting a moveBYBIT:GALAUSDT.P is trading near the key $0.02490 level, forming a consolidation zone before a potential breakout. Volume is increasing, and price is holding above POC $0.02255, confirming strong buyer activity. A breakout above $0.02495 could trigger an accelerated move toward $0.02520 – $0.02565. 📈 LONG BYBIT:GALAUSDT.P from $0.02495 🛡 Stop Loss: $0.02460 ⏱ 1H Timeframe ✅ Overview: ➡️ BYBIT:GALAUSDT.P is approaching $0.02495, a key resistance level. ➡️ Price remains above POC $0.02255, confirming strong buyer interest. ➡️ Increasing volume supports the potential bullish move. ⚡ Plan: 🔵 Holding above $0.02495 increases the chance of an uptrend. 🔵 Main support at $0.02460 – losing this level invalidates the setup. 🔵 Target zones – $0.02520, $0.02540, and $0.02565, where profit-taking is expected. 🎯 Take Profit: 💎TP1: $0.02520 – first profit-taking zone. 💎 TP2: $0.02540 – strong resistance level. 💎 TP3: $0.02565 – final upside target. 📢 Recommendations: ✅ Bullish confirmation requires a strong close above $0.02495. ✅ If price slows down at $0.02520, partial profit-taking is recommended. ✅ A drop below $0.02460 invalidates the setup. 🚀 BYBIT:GALAUSDT.P is breaking resistance – expecting a move to $0.02565! 📢 Holding above $0.02495 opens the door for further gains. Watch volume closely – if it weakens, price may consolidate. 📢 Entry above $0.02495, targets at $0.02520 – $0.02565. 📢 Partial profit-taking recommended at $0.02540. 📢 If price drops below $0.02460, the setup is invalidated. 📌 Strategy: Resistance Breakout + Profit Targeting at Key Levels.
Long
by MoriartyTrading
#SWELLUSDT longsignal📉 LONG BYBIT:SWELLUSDT.P from $0.01928 🛡 Stop Loss: $0.01890 ⏱ 1H Timeframe ✅ Overview: ➡️ BYBIT:SWELLUSDT.P is showing a strong upward movement after breaking out of consolidation. The price has broken key resistance levels and is now forming a retest zone, confirming bullish strength. ➡️ POC (Point of Control) is located at $0.01175, far below the current price, indicating a shift to a new accumulation phase. ➡️ Trading volumes have increased significantly, which could further strengthen the upward impulse. ⚡ Plan: ➡️ Enter LONG at $0.01928 after confirming the breakout level. ➡️ Stop-Loss set at $0.01890 to protect against false breakouts. ➡️ Primary targets – $0.01967, $0.02013, and $0.02065, where partial profit-taking is possible. 🎯 TP Targets: 💎 TP1: $0.01967 🔥 TP2: $0.02013 ⚡ TP3: $0.02065 🚀 Expectation: If the current trend holds, BYBIT:SWELLUSDT.P may continue its upward movement towards $0.02065 and beyond.
Long
by MoriartyTrading
Novo Nordisk's The recent drop in Novo Nordisk's stock price is attributed to several factors. A key issue is the company’s struggle to meet the surging demand for its weight-loss drugs, such as Wegovy. Although demand remains strong, investors are concerned about Novo Nordisk's ability to scale up production and deliveries, which is creating downward pressure on the stock. Additionally, some recent financial results failed to meet Wall Street expectations. Despite revenue growth in key product categories, overall revenues in some reports came in below forecasts. This underperformance has contributed to a negative investor sentiment. However, analysts emphasize that Novo Nordisk's core products remain in high demand, and the company has significant long-term growth potential if it addresses its supply chain and production challenges
OMXCOP:NOVO_BLong
by ForexCompany
ICP Leading the Way - TP Target $23.04 I am waiting on a pullback to enter ICP as it leads the way with a good increase in volume that hasn't been reflected in most other coins despite their increase in price. Most coins I am seeing overbought signals on the 4 hour suggesting an opportunity for a pull back. For ICP, I am looking at buys at approx. 11.54 and 10.90 before we keep moving (VWAP's on 4 hr and Daily). TP's depend on how long you like to hold, Fib Level 1.618 is 23.04 for an optimistic target, most likely TP along the way to this.
Long
by Off-The-Chart-CTC